| Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations (NCT02149823) | Maria de las Mercedes Perez Rodriguez | 2013-09-01 |
| TP0502-B-Pharmaco-Scintigraphic-Study (NCT02306798) | Tillotts Pharma AG | 2013-09-01 |
| Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) (NCT02859129) | AstraZeneca | 2013-09-01 |
| Virus DNX2401 and Temozolomide in Recurrent Glioblastoma (NCT01956734) | Clinica Universidad de Navarra, Universidad de Navarra | 2013-09-01 |
| A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors. (NCT01916447) | Taiho Oncology, Inc. | 2013-09-01 |
| Pilot Study of Redirected Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia (NCT01974479) | National University Health System, Singapore | 2013-09-01 |
| A Clinical Trial to Investigate the Pharmacokinetics and the Effect on ECG of Escitalopram in Elderly Volunteers (NCT02122939) | Seoul National University Hospital | 2013-09-01 |
| PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma (NCT01939665) | Amsterdam UMC, location VUmc | 2013-09-01 |
| Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease (NCT02032446) | A.O. Ospedale Papa Giovanni XXIII | 2013-09-01 |
| Study of ORL-1B in Patients With Biotinidase Deficiency (NCT03269045) | Orpha Labs | 2013-08-31 |
| Effects of Exercise on Memory in Healthy and Brain-Injured Individuals (NCT01939769) | National Institute of Neurological Disorders and Stroke (NINDS) | 2013-08-31 |
| Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL (NCT01994382) | Alexion Pharmaceuticals, Inc. | 2013-08-30 |
| A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes (NCT01934712) | Novo Nordisk A/S | 2013-08-30 |
| Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response (NCT01933906) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2013-08-30 |
| Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi (NCT01946711) | Pari Pharma GmbH | 2013-08-28 |
| Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery (NCT01940809) | National Cancer Institute (NCI) | 2013-08-28 |
| Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) (NCT01742286) | Novartis Pharmaceuticals | 2013-08-28 |
| INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer (NCT01911507) | University of California, Davis | 2013-08-27 |
| The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult Subjects (NCT01905553) | Shire | 2013-08-27 |
| Utilization of Autologous Mesenchymal Cells in Posterolateral Spinal Fusion in Degenerative Spine Disease (NCT03827096) | Bioinova, s.r.o. | 2013-08-27 |
| Knee Osteoarthritis With Stromal Vascular Fraction Cells (NCT07259993) | Michael H Carstens | 2013-08-27 |
| Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation (NCT01915498) | Celgene | 2013-08-27 |
| Study of Acamprosate in Fragile x Syndrome (NCT01911455) | Children's Hospital Medical Center, Cincinnati | 2013-08-27 |
| Immunogenicity and Safety Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals H7N1 Influenza Vaccine Administered to Adults 21 to 64 Years of Age (NCT01934127) | GlaxoSmithKline | 2013-08-26 |
| Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction (NCT01907802) | National Cancer Institute (NCI) | 2013-08-23 |
| Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer (NCT03332576) | ImmunoVaccine Technologies, Inc. (IMV Inc.) | 2013-08-23 |
| Phase 1 Study of OTS167 in Patients With Solid Tumors (NCT01910545) | OncoTherapy Science, Inc. | 2013-08-23 |
| Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer (NCT02092948) | Jonsson Comprehensive Cancer Center | 2013-08-22 |
| VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected... (NCT01950325) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-08-22 |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma (NCT01808820) | Macarena De La Fuente, MD | 2013-08-21 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma (NCT01962532) | Janssen Research & Development, LLC | 2013-08-21 |
| Ixazomib With Cyclophosphamide and Dexamethasone in Patients With Previously Untreated Symptomatic Multiple Myeloma or Light Chain Amyloidosis (NCT01864018) | Mayo Clinic | 2013-08-20 |
| A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants (NCT01767623) | Hoffmann-La Roche | 2013-08-20 |
| Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult Volunteers (NCT03979859) | Wockhardt | 2013-08-20 |
| A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier. (NCT01924858) | GlaxoSmithKline | 2013-08-19 |
| Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients. (NCT01898364) | Genzyme, a Sanofi Company | 2013-08-19 |
| A Study of Vemurafenib (Zelboraf) in Chinese Participants With BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma (NCT01910181) | Hoffmann-La Roche | 2013-08-17 |
| A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis (NCT01904292) | Hoffmann-La Roche | 2013-08-15 |
| Brain Networks and Addiction Susceptibility (NCT01924468) | National Institute on Drug Abuse (NIDA) | 2013-08-14 |
| Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer (NCT01848067) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-08-14 |
| Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors (NCT01639911) | University of Illinois at Chicago | 2013-08-14 |
| MRI-Guided Laser Surgery and Doxorubicin Hydrochloride in Treating Patients With Recurrent Glioblastoma Multiforme (NCT01851733) | Washington University School of Medicine | 2013-08-13 |
| Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia (NCT01898884) | Shire | 2013-08-13 |
| Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma (NCT01898715) | Millendo Therapeutics, Inc. | 2013-08-13 |
| A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy Subjects (NCT01923207) | Shire | 2013-08-12 |
| Phase 1 Dose Escalating Study to Assess Safety, Tolerability, Food Effect and PK of CHR-5154 in Healthy Male Volunteers (NCT01934101) | GlaxoSmithKline | 2013-08-12 |
| A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis (NCT01900574) | Janssen Research & Development, LLC | 2013-08-09 |
| Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer (NCT01924260) | Edward Kim | 2013-08-09 |
| A Study Of PF-06263507 In Patients With Advanced Solid Tumors (NCT01891669) | Pfizer | 2013-08-08 |
| A Study of ABT-165 in Subjects With Solid Tumors (NCT01946074) | AbbVie | 2013-08-08 |
| A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects (NCT01818011) | GlaxoSmithKline | 2013-08-07 |
| A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein (NCT01918254) | Hoffmann-La Roche | 2013-08-06 |
| A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of N-Rephasin® SAL200 in Healthy Male Volunteers (NCT01855048) | Intron Biotechnology, Inc. | 2013-08-06 |
| Aerosolized and Intravenous Colistin in Healthy Adults (NCT01863719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-08-06 |
| Single Rising Doses of BI 655064 in Healthy Chinese and Japanese Male Volunteers (NCT01917916) | Boehringer Ingelheim | 2013-08-05 |
| A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt) (NCT01905540) | Shire | 2013-08-05 |
| ROTAHALER Device Optimization Study (NCT01890863) | GlaxoSmithKline | 2013-08-05 |
| A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian (NCT01952249) | OncoMed Pharmaceuticals, Inc. | 2013-08-05 |
| Lenalidomide and Idelalisib in Treating Patients With Recurrent Follicular Lymphoma (NCT01644799) | Alliance for Clinical Trials in Oncology | 2013-08-02 |
| Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene (NCT01852071) | University of California, Los Angeles | 2013-08-02 |
| Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation (NCT01841463) | Piramal Enterprises Limited | 2013-08-01 |
| A Study of LY2409021 in Participants With Different Levels of Kidney Function (NCT01929109) | Eli Lilly and Company | 2013-08-01 |
| A Study of LY3050258 in Healthy Participants (NCT01929707) | Eli Lilly and Company | 2013-08-01 |
| Effects of Sertraline on Brain Connectivity in Adolescents With OCD (NCT02797808) | University of Minnesota | 2013-08-01 |
| A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian Cancer (NCT02093871) | ThermalCore Inc | 2013-08-01 |
| RX-5902 Treatment of Subjects With Triple Negative Breast Cancer (NCT02003092) | Rexahn Pharmaceuticals, Inc. | 2013-08-01 |
| Pharmacokinetics Study of NI-071 (NCT01931189) | Nichi-Iko Pharmaceutical Co., Ltd. | 2013-08-01 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes (NCT01924637) | Novo Nordisk A/S | 2013-08-01 |
| Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in China (NCT01933776) | Sanofi Pasteur, a Sanofi Company | 2013-08-01 |
| Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration (NCT01929213) | Dong-A Pharmaceutical Co., Ltd. | 2013-08-01 |
| Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the Elderly (NCT02125305) | Seoul National University Hospital | 2013-08-01 |
| Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis (NCT02132260) | Sun Pharmaceutical Industries, Inc. | 2013-08-01 |
| OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects. (NCT01925521) | Korea Otsuka Pharmaceutical Co., Ltd. | 2013-08-01 |
| Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer (NCT01923337) | University of California, Davis | 2013-08-01 |
| ARRY-380 + Trastuzuamab for Breast w/ Brain Mets (NCT01921335) | Dana-Farber Cancer Institute | 2013-08-01 |
| PK of Serelaxin in Severe Renal Impairment and ESRD (NCT01875523) | Novartis Pharmaceuticals | 2013-08-01 |
| The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018) (NCT01832103) | Merck Sharp & Dohme LLC | 2013-08-01 |
| Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male Volunteers (NCT01922349) | Boehringer Ingelheim | 2013-08-01 |
| Dovitinib Plus Docetaxel in Gastric Cancer (NCT01921673) | Asan Medical Center | 2013-08-01 |
| A PET Study With RO5545965 in Healthy Male Volunteers (NCT01923025) | Hoffmann-La Roche | 2013-08-01 |
| A Study of RO6870868 in Healthy Volunteers (NCT01911611) | Hoffmann-La Roche | 2013-08-01 |
| A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants (NCT01745120) | Genetix Biotherapeutics Inc. | 2013-08-01 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of MEDI9929 After Single Administration in Healthy Male Japanese Subjects (NCT01913028) | AstraZeneca | 2013-08-01 |
| Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P (NCT01919944) | Vanda Pharmaceuticals | 2013-08-01 |
| A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants (NCT01924299) | Eli Lilly and Company | 2013-08-01 |
| Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic Insufficiency (NCT01916993) | Neurocrine Biosciences | 2013-08-01 |
| Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma (NCT01933815) | Cortice Biosciences, Inc. | 2013-08-01 |
| Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer (NCT01939418) | National Cancer Center, Korea | 2013-08-01 |
| Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors (NCT01910597) | Prince of Songkla University | 2013-08-01 |
| Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis (NCT02267694) | UConn Health | 2013-08-01 |
| Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy (NCT02728492) | NewVac LLC | 2013-08-01 |
| A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects (NCT01980589) | Amgen | 2013-08-01 |
| A PK Study GL2702 GLARS-NF1 and Omix Ocas® in Healthy Male Volunteers (NCT02072213) | GL Pharm Tech Corporation | 2013-08-01 |
| Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis (NCT02070237) | MemorialCare Health System | 2013-08-01 |
| Extended Use of Sodium Bicarbonate in Patients With Cancer (NCT02531919) | University of Arizona | 2013-08-01 |
| A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers (NCT01954238) | Green Cross Corporation | 2013-08-01 |
| Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes (NCT02140983) | Stanford University | 2013-08-01 |
| Study to Assess Safety and Efficacy of Fingolimod in Children With Rett Syndrome (NCT02061137) | University Hospital, Basel, Switzerland | 2013-08-01 |
| PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily (NCT01915901) | Biogen | 2013-08-01 |
| A Study to Evaluate the Effect of IV Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult Subjects (NCT01941511) | GlycoMimetics Incorporated | 2013-08-01 |